Skip to main content
TipRanks
Go Ultimate75% OFF

INVO Fertility (IVF) Ratios

282 Followers

INVO Fertility Ratios

IVF's free cash flow for Q2 2026 was $-911.02K. For the 2026 fiscal year, IVF's free cash flow was increased by $190.43K and operating cash flow was $-1.10M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio0.270.070.160.195.03
Quick Ratio0.250.060.120.114.80
Cash Ratio0.200.040.030.034.54
Solvency Ratio-1.74-0.24-0.44-2.31-2.06
Operating Cash Flow Ratio-0.68-0.17-0.59-1.98-4.81
Short-Term Operating Cash Flow Coverage-5.50-0.47-3.15-8.660.00
Net Current Asset Value$ -10.23M$ -32.38M$ -16.35M$ -4.07M$ 3.15M
Leverage Ratios
Debt-to-Assets Ratio0.170.210.340.610.20
Debt-to-Equity Ratio0.470.787.06-2.320.29
Debt-to-Capital Ratio0.320.440.881.760.23
Long-Term Debt-to-Capital Ratio0.090.080.580.000.00
Financial Leverage Ratio2.803.6420.73-3.791.43
Debt Service Coverage Ratio-1.30-0.96-2.84-13.08-4.13
Interest Coverage Ratio-4.49-7.69-7.31-178.76-4.12
Debt to Market Cap4.580.150.000.000.00
Interest Debt Per Share160.62257.332.310.961.59
Net Debt to EBITDA-0.38-1.28-0.88-0.200.68
Profitability Margins
Gross Profit Margin36.96%44.00%35.96%-3.48%96.51%
EBIT Margin-61.16%-123.43%-234.42%-1317.23%-129.44%
EBITDA Margin-51.26%-109.35%-227.77%-1307.83%-125.45%
Operating Profit Margin-85.36%-124.40%-224.04%-1292.45%-125.39%
Pretax Profit Margin-80.20%-139.60%-265.08%-1324.46%-159.86%
Net Profit Margin-340.92%-139.25%-266.00%-1324.81%-159.97%
Continuous Operations Profit Margin-78.00%-139.25%-266.00%-1324.81%-159.97%
Net Income Per EBT425.11%99.75%100.35%100.03%100.07%
EBT Per EBIT93.94%112.22%118.32%102.48%127.48%
Return on Assets (ROA)-115.35%-19.58%-43.42%-293.61%-63.58%
Return on Equity (ROE)-322.85%-71.35%-899.91%1114.20%-91.03%
Return on Capital Employed (ROCE)-59.06%-28.49%-64.43%-2858.12%-56.62%
Return on Invested Capital (ROIC)-49.95%-23.09%-55.49%-820.81%-55.29%
Return on Tangible Assets-179.19%-189.12%-94.15%-293.61%-64.40%
Earnings Yield-5290.82%-18.32%-0.70%-0.18%-0.02%
Efficiency Ratios
Receivables Turnover31.4937.3521.4910.6682.43
Payables Turnover2.120.640.830.630.33
Inventory Turnover19.1516.647.313.230.50
Fixed Asset Turnover4.092.370.720.441.64
Asset Turnover0.340.140.160.220.40
Working Capital Turnover Ratio-0.57-0.56-0.640.700.63
Cash Conversion Cycle-141.49-538.48-372.82-431.43-387.24
Days of Sales Outstanding11.599.7716.9834.254.43
Days of Inventory Outstanding19.0621.9349.91113.09724.13
Days of Payables Outstanding172.15570.18439.71578.771115.80
Operating Cycle30.6631.7066.89147.34728.56
Cash Flow Ratios
Operating Cash Flow Per Share-239.64-69.89-1.52-2.72-2.84
Free Cash Flow Per Share-241.12-74.20-1.66-2.73-3.05
Dividend Paid and CapEx Coverage Ratio-161.58-16.19-10.69-518.80-13.26
Capital Expenditure Coverage Ratio-161.58-16.19-10.69-518.80-13.26
Operating Cash Flow Coverage Ratio-2.06-0.30-0.75-2.91-2.84
Operating Cash Flow to Sales Ratio-1.03-0.46-1.57-8.03-1.45
Free Cash Flow Yield-1601.08%-6.36%-0.45%-0.11%-0.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.06-5.31-143.70-543.61-6128.92
Price-to-Sales (P/S) Ratio0.067.60382.237201.769804.44
Price-to-Book (P/B) Ratio0.063.891293.14-6056.865579.18
Price-to-Free Cash Flow (P/FCF) Ratio-0.06-15.72-222.04-894.98-6289.95
Price-to-Operating Cash Flow Ratio-0.06-16.69-242.80-896.71-6764.21
Price-to-Earnings Growth (PEG) Ratio0.000.103.35-12.48104.17
Enterprise Value Multiple-0.50-8.23-168.69-550.87-7814.93
Enterprise Value1.76M58.80M1.16B5.92B40.78B
EV to EBITDA-0.50-8.23-168.69-550.87-7814.93
EV to Sales0.269.00384.247204.419803.58
EV to Free Cash Flow-0.25-18.62-223.20-895.31-6289.40
EV to Operating Cash Flow-0.25-19.77-244.08-897.04-6763.62
Tangible Book Value Per Share0.69-678.86-2.90-0.403.38
Shareholders’ Equity Per Share246.80299.520.29-0.403.44
Tax and Other Ratios
Effective Tax Rate0.030.00-0.00-0.00-0.00
Revenue Per Share233.72153.480.960.341.96
Net Income Per Share-796.80-213.72-2.57-4.49-3.13
Tax Burden4.251.001.001.001.00
Interest Burden1.311.131.131.011.23
Research & Development to Revenue0.000.070.050.660.05
SG&A to Revenue1.121.390.000.000.00
Stock-Based Compensation to Revenue0.210.240.462.710.65
Income Quality0.300.330.590.610.91

Currency in USD